KIMBERLY AGIM: Open Payments
NPI 1912243056 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,857 in 11 payments from 5 companies in 2025. Trend: 2023 $542 · 2024 $661 · 2025 $3,857
Consulting: $2,400Food & beverage: $735Travel & lodging: $722
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $3,661 |
| Janssen Biotech, Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Amgen Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: FABRAZYME, Fabhalta, UPLIZNA, TEZSPIRE.
Industry payments across MI — which companies pay providers there.
